160 related articles for article (PubMed ID: 1878079)
21. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
[TBL] [Abstract][Full Text] [Related]
22. Pyridinium crosslinks in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Ibrahim S; Mojiminiyi S; Barron JL
Nephrol Dial Transplant; 1995 Dec; 10(12):2290-4. PubMed ID: 8808228
[TBL] [Abstract][Full Text] [Related]
23. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
[TBL] [Abstract][Full Text] [Related]
24. Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis.
Stevenson DA; Schwarz EL; Viskochil DH; Moyer-Mileur LJ; Murray M; Firth SD; D'Astous JL; Carey JC; Pasquali M
Pediatr Res; 2008 Jun; 63(6):697-701. PubMed ID: 18317233
[TBL] [Abstract][Full Text] [Related]
25. Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.
Pecherstorfer M; Seibel MJ; Woitge HW; Horn E; Schuster J; Neuda J; Sagaster P; Köhn H; Bayer P; Thiébaud D; Ludwig H
Blood; 1997 Nov; 90(9):3743-50. PubMed ID: 9345061
[TBL] [Abstract][Full Text] [Related]
26. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
[TBL] [Abstract][Full Text] [Related]
27. Immunoassay for urinary pyridinoline: the new marker of bone resorption.
Seyedin SM; Kung VT; Daniloff YN; Hesley RP; Gomez B; Nielsen LA; Rosen HN; Zuk RF
J Bone Miner Res; 1993 May; 8(5):635-41. PubMed ID: 8511991
[TBL] [Abstract][Full Text] [Related]
28. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
29. Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats.
Vanderschueren D; Jans I; van Herck E; Moermans K; Verhaeghe J; Bouillon R
Bone Miner; 1994 Aug; 26(2):123-31. PubMed ID: 7994184
[TBL] [Abstract][Full Text] [Related]
30. Collagen cross-links as a marker for subclinical atherosclerosis in postmenopausal women.
Caglar GS; Kahyaoglu I; Ozdemir ED; Seker R; Demirtas S
Menopause; 2014 Jan; 21(1):74-8. PubMed ID: 23736860
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism.
Nakamura H; Mori T; Genma R; Suzuki Y; Natsume H; Andoh S; Kitahara R; Nagasawa S; Nishiyama K; Yoshimi T
Clin Endocrinol (Oxf); 1996 Apr; 44(4):447-51. PubMed ID: 8706312
[TBL] [Abstract][Full Text] [Related]
32. Excretion of pyridinium cross-links of collagen in ovariectomized rats as urinary markers for increased bone resorption.
Black D; Farquharson C; Robins SP
Calcif Tissue Int; 1989 May; 44(5):343-7. PubMed ID: 2496906
[TBL] [Abstract][Full Text] [Related]
33. The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab.
Ostanek L; Pawlik A; Brzosko I; Brzosko M; Sterna R; Droździk M; Gawrońska-Szklarz B
Clin Rheumatol; 2004 Jun; 23(3):214-7. PubMed ID: 15168147
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat.
Egger CD; Mühlbauer RC; Felix R; Delmas PD; Marks SC; Fleisch H
J Bone Miner Res; 1994 Aug; 9(8):1211-9. PubMed ID: 7976504
[TBL] [Abstract][Full Text] [Related]
35. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer.
Paterson CR; Robins SP; Horobin JM; Preece PE; Cuschieri A
Br J Cancer; 1991 Nov; 64(5):884-6. PubMed ID: 1931610
[TBL] [Abstract][Full Text] [Related]
36. Diurnal variation in concentrations of various markers of bone metabolism in dogs.
Liesegang A; Reutter R; Sassi ML; Risteli J; Kraenzlin M; Riond JL; Wanner M
Am J Vet Res; 1999 Aug; 60(8):949-53. PubMed ID: 10451203
[TBL] [Abstract][Full Text] [Related]
37. Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds.
Husain SM; Mughal Z; Williams G; Ward K; Smith CS; Dutton J; Fraser WD
Arch Dis Child; 1999 Apr; 80(4):370-3. PubMed ID: 10086947
[TBL] [Abstract][Full Text] [Related]
38. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases.
Seibel MJ; Duncan A; Robins SP
J Rheumatol; 1989 Jul; 16(7):964-70. PubMed ID: 2769668
[TBL] [Abstract][Full Text] [Related]
39. Evaluation and comparison of urinary pyridinium crosslinks in two rat models of bone loss--ovariectomy and adjuvant polyarthritis--using a new automated HPLC method.
Tordjman C; Lhumeau A; Pastoureau P; Meunier F; Serkiz B; Volland JP; Bonnet J
Bone Miner; 1994 Aug; 26(2):155-67. PubMed ID: 7994187
[TBL] [Abstract][Full Text] [Related]
40. [The biochemical markers of bone remodeling in cancer patients with skeletal involvement].
Liubimova NV; Bronnikov IIu; Robins SP; Trapeznikova MF; Kushlinskiĭ NE
Vopr Onkol; 2000; 46(3):290-7. PubMed ID: 10976274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
